Cross-protective multivalent vaccine for tick-borne flaviviruses

Ended Project Grant Awarded Last action

Award ID
R44AI118017
Recipient
Awarding agency
Obligated
$6,957,154

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Funding
  • $6,080,442.00 Federal
  • $876,712.00 Non-federal
Place of performance
Honolulu, HI 96817, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $876,712 $0
Amendment $876,712 $876,712
Amendment $984,053 $0
Amendment $0 $0
Amendment $389,739 $0
Amendment $0 $0
Amendment $839,920 $0
Amendment $0 $0
Amendment $0 $0
Amendment $956,757 $0
Original award $1,156,549 $0
Show all 12

Quick answers

Who received award R44AI118017?

R44AI118017 was awarded to Hawaii Biotech, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 6, 2015.

How much is award R44AI118017 worth?

$6,957,154 has been obligated on R44AI118017: $6,080,442 in federal funding and $876,712 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award